Aoxiang Pharmaceutical (603229)
Overview
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional in
Employees1328
Market Cap$7.8B
Revenue$794.8M
Listed OnShanghai Stock Exchange
Ticker603229
CEOMr. Zhiguo Zheng
HeadquartersLinhai